10-Q: Arteris Reports Q2 Revenue Growth Amid Rising Costs

Arteris, Inc. reported a 13% increase in second-quarter revenue to $16.5 million, driven by new license agreements and royalty growth, though net loss widened to $9.1 million.

Summary

• Revenue for the three months ended June 30, 2025, increased by 13% to $16.5 million, compared to $14.6 million in the prior year period.
• For the six months ended June 30, 2025, total revenue grew by 20% to $33.0 million, up from $27.5 million in the same period of 2024.
• Licensing, support, and maintenance revenue increased by 11% in Q2 2025 to $15.1 million and by 20% for the six months to $30.4 million.
• Variable royalties and other revenue grew by 38% in Q2 2025 to $1.4 million and by 44% for the six months to $2.6 million.
• Net loss for Q2 2025 was $9.1 million, compared to $8.3 million in Q2 2024.
• Net loss for the six months ended June 30, 2025, was $17.3 million, a slight improvement from $17.7 million in the prior year period.
• Operating expenses increased by 12% in Q2 2025 to $23.0 million and by 11% for the six months to $45.7 million, primarily due to higher employee-related costs in research and development and sales and marketing.
• Annual Contract Value (ACV) reached $63.9 million as of June 30, 2025, up from $56.1 million as of June 30, 2024.
• Confirmed Design Starts increased to 25 during Q2 2025, compared to 21 in Q2 2024.
• Remaining Performance Obligations (RPO) grew to $99.3 million as of June 30, 2025, from $77.5 million as of June 30, 2024.
• The accumulated deficit increased to $154.1 million as of June 30, 2025, from $136.9 million as of December 31, 2024.
• Net cash provided by operating activities for the six months ended June 30, 2025, was $0.4 million, down from $0.8 million in the prior year period.

Sentiment

Score: 4

Explanation: While revenue and key performance indicators show growth, the company continues to incur significant net losses, and its accumulated deficit is increasing. Operating expenses are rising, and cash from operations has declined. The equity method investment is a drag, requiring further capital. Significant geopolitical and trade risks, particularly concerning China, pose ongoing challenges. The overall financial health, as indicated by the growing deficit and cash flow trends, is concerning despite top-line growth.

Positives

• Strong revenue growth: 13% increase in Q2 2025 and 20% increase for the six months ended June 30, 2025, driven by new license agreements and existing customer expansion.
• Significant growth in variable royalty revenue, up 44% for both the three and six months ended June 30, 2025, indicating increased product sales by customers incorporating the company's IP.
• Key performance indicators show positive trends: Annual Contract Value (ACV) increased to $63.9 million, Confirmed Design Starts rose to 25, and Remaining Performance Obligations (RPO) grew to $99.3 million.
• Reduced net loss for the six months ended June 30, 2025, at $17.3 million compared to $17.7 million in the prior year period.
• General and administrative expenses decreased by 7% in Q2 2025 and 4% for the six months, indicating some cost management.
• All claims against the company in the NST patent infringement litigation were dismissed without prejudice on September 4, 2024.
• The recently enacted "One Big Beautiful Bill Act" (OBBBA) on July 4, 2025, includes permanent reinstatement of bonus depreciation and full expensing of domestic research and experimental expenditures, which could positively impact future tax liabilities.

Negatives

• Continued net losses: $9.1 million in Q2 2025 and $17.3 million for the six months ended June 30, 2025.
• Accumulated deficit significantly increased to $154.1 million as of June 30, 2025, from $136.9 million at December 31, 2024.
• Operating expenses grew faster than revenue in Q2 2025, increasing by 12% while revenue increased by 13%.
• Research and development expenses increased by 14% in Q2 2025 and 12% for the six months, reflecting increased headcount and professional fees.
• Sales and marketing expenses increased significantly by 26% in Q2 2025 and 23% for the six months, primarily due to higher employee-related costs and increased headcount.
• Net cash provided by operating activities decreased to $0.4 million for the six months ended June 30, 2025, from $0.8 million in the prior year period.
• Net cash provided by investing activities significantly decreased to $0.6 million for the six months ended June 30, 2025, from $7.5 million in the prior year period.
• Loss from equity method investment (Transchip) continues, with $0.8 million in Q2 2025 and $1.6 million for the six months, and Transchip's ability to continue operations is dependent on raising additional capital.
• A reversal of $0.7 million in accounts receivable and deferred revenue related to a collaboration agreement with Transchip occurred due to contract criteria not being met.
• Revenue from customers located in China decreased to 25.0% for the six months ended June 30, 2025, from 29.2% in 2024, with an expectation for further decrease due to U.S. government trade restrictions.

Risks

• Significant competition from larger companies and third-party providers, including those that develop IP solutions internally, potentially leading to increased pressure to lower prices, higher sales and marketing expenses, or market share loss.
• History of net losses and no assurance of future profitability, with net losses potentially fluctuating significantly due to geopolitical and market factors, inflation, and economic slowdowns.
• Dependence on customers incorporating IP solutions into their end products and the market acceptance of those end products; delays in customer product design cycles or lack of market success for customer products could adversely affect revenue.
• Reliance on market acceptance of third-party semiconductor IP, with potential harm to business if this model does not gain wider adoption or if customers shift away from licensing third-party IP.
• Risk of not sustaining or growing licensing revenue, which would materially decline results of operations, given the lengthy and unpredictable customer acquisition and renewal cycles.
• Significant expenses incurred in the design win process without guarantee of revenue, potentially adversely affecting financial results if bids are not selected.
• Even after securing design wins, there is no guarantee of timely or sufficient margins or royalty revenue due to factors like extended development cycles, production delays, market pressures, or product defects.
• Failure to successfully carry out new IP interconnect, SoC integration automation, and other technology initiatives, or to anticipate technological changes, could lead to loss of competitive position or product obsolescence.
• Potential need to invest more resources in research and development than anticipated, increasing operating expenses without a corresponding revenue increase.
• Product errors or defects could expose the company to liability, harm its reputation, and lead to market share loss.
• Failure to offer high-quality products and support could damage reputation and hinder customer retention and expansion.
• Dependence on international customers and operations subjects the company to regulatory, operational, financial, and political risks, including export control regulations, tariffs, and foreign exchange rate fluctuations.
• Changes in U.S. and other countries' legislation and regulation, including new trade policies and tariffs, may adversely impact business, results of operations, and financial condition.
• The cyclical nature of the semiconductor industry, including significant supply chain disruption, may limit the ability to maintain or improve revenue.
• Revenue concentration among a small number of licensees and customers, with the loss of any key customer potentially leading to substantial revenue decrease.
• Failure to effectively expand sales and marketing capabilities could harm the ability to increase customer base and achieve broader market acceptance of products.
• Risks associated with the development and use of generative artificial intelligence, including potential for malfunctioning, biased results, ethical concerns, privacy violations, and intellectual property risks.
• Seasonal fluctuations in sales, with historically lowest new license agreements in the first and second calendar quarters, and dependence on specific end markets like automotive, which are subject to their own risks.
• Royalty rates could decrease for existing and future license agreements due to market pressures, competitive pricing, or changes in product mix, materially adversely affecting operating results.
• Acquisitions and investments in new businesses, products, or technologies, joint ventures, and other strategic transactions involve numerous risks, including integration challenges, unknown liabilities, and potential underperformance.
• Ability to raise capital in the future may be limited, potentially preventing execution of growth strategy or requiring additional financing on unfavorable terms.
• Inability to effectively manage growth, requiring significant expenditures for operational and control requirements.
• Dependence on key and highly skilled personnel, with risks related to retention and hiring, especially for engineers.
• Management team has limited experience managing a public company, potentially diverting attention and increasing compliance costs.
• Catastrophic events (e.g., earthquakes, cyber-attacks, wars, disease outbreaks) could disrupt business operations.
• Counterparties' inability to fulfill financial obligations could adversely affect business and results of operations.
• Inability to protect proprietary technology and inventions through patents and other intellectual property rights, or the risk of unauthorized disclosure of trade secrets.
• Risk of infringing on others' intellectual property rights, leading to litigation, damages, injunctions, or costly redesigns.
• Inability to obtain or maintain licenses to third-party software and intellectual property on reasonable terms, potentially disrupting business.
• Disputes regarding intellectual property may require indemnification of customers, leading to substantial expenses.
• Cybersecurity threats, including attacks or prolonged outages, could interrupt information technology systems, cause data loss, incur excessive costs, or harm reputation.
• Non-compliance with data protection, AI, privacy, and security laws and regulations across different markets could harm business, leading to fines, litigation, or reputational damage.
• Failure to comply with a large body of laws and regulations (e.g., anti-trust, consumer protection, worker safety, environmental protection, employment matters, anti-corruption) could lead to investigations, sanctions, and fines.
• Loss of sales if unable to obtain government authorization to export certain products and services, or legal/regulatory consequences for non-compliance with export control laws.
• Specific risks associated with doing business in China, including economic, political, legal, and social conditions, government influence, currency exchange restrictions, intellectual property theft, and increased export sanctions.
• Risks associated with joint venture arrangements with Chinese entities, including potential non-compliance with regulations, differing interests, and IP infringement.
• Social and environmental responsibility regulations and customer/investor demands may complicate the supply chain and affect relationships.
• Changes in tax rates or new tax legislation, or exposure to additional tax liabilities, could harm business.
• Ability to use net operating losses (NOLs) to offset future taxable income may be limited due to ownership changes.
• Requirements of being a public company require significant resources and management attention, affecting ability to attract and retain talent.
• Failure to maintain effective disclosure controls and internal control over financial reporting could impair ability to produce timely and accurate financial statements.
• As an emerging growth company, reduced disclosure requirements may make common stock less attractive to investors.
• An active and liquid trading market for common stock may not be sustained, and stock price may be volatile.
• Sales of substantial number of shares by existing stockholders could cause stock price to fall.
• K. Charles Janac's significant ownership (22.2%) allows him to exert significant control.
• Issuance of additional capital stock could dilute ownership and voting power.
• No expectation to declare or pay dividends for the foreseeable future.
• Anti-takeover provisions in corporate documents and Delaware General Corporation Law (DGCL) could prevent or discourage takeovers.
• Exclusive forum provisions in Certificate of Incorporation could limit stockholders' ability to obtain a favorable judicial forum.
• Actions of stockholders could cause substantial costs and divert management attention.

Future Outlook

The company expects research and development expenses to increase in absolute terms and as a percentage of revenue in the short term, then decrease as a percentage of revenue in the medium to longer term. Sales and marketing expenses are also anticipated to increase in absolute terms but decrease as a percentage of revenue due to productivity improvements. General and administrative expenses are expected to increase as the business grows but generally decrease as a percentage of revenue over the long term. Losses from the equity method investment in Transchip are expected to continue in the near future, with Transchip's operations dependent on raising additional capital. Revenue from China is expected to decrease due to U.S. government trade restrictions. The company believes its existing cash, cash equivalents, investments, and cash from sales will be sufficient for at least the next 12 months, but acknowledges that additional financing may be required if resources are insufficient.

Management Comments

• Our SoC Integration Automation software solutions, which were significantly enhanced by our acquisition of Magillem Design Services S.A. (Magillem) in 2020, complement our interconnect IP solutions by helping to automate not only the customer configuration of its NoC interconnect but also the process of integrating and assembling all of the customers IP blocks into an SoC.
• Artificial Intelligence (AI) and Generative AI are transforming the semiconductor industry, revolutionizing how our customers approach design and development. The rapid expansion of AI applications across various industries, combined with the increasing complexity of electronic system design, has unlocked new growth opportunities, driving a positive impact on our financial performance.
• We believe our products global footprint provides us with the opportunity to enter new markets and accelerate our growth.
• We expect cost of revenue as a percentage of revenue to modestly decline over time due to productivity improvements of our FAE processes.
• We expect R&D expenses to increase in absolute terms and as a percentage of revenue in the short term and to continue to increase in absolute terms in the medium to long term but decrease as a percentage of revenue as certain new products are launched.
• We expect S&M expenses to continue to increase in absolute terms but decrease as a percentage of revenue due to productivity improvements of our sales processes.
• We expect G&A expenses to increase as our business grows. In addition, we expect G&A expenses as a percentage of revenue to vary from period to period but generally decrease over the long term.
• We believe our cash and cash equivalents, investments and cash provided by sales of our products will be sufficient to meet our expected working capital needs, capital expenditures, financial commitments and other liquidity requirements associated with our existing operations for at least the next 12 months.

Industry Context

Arteris operates in the semiconductor system IP industry, providing interconnect and other intellectual property (IP) technology for System-on-Chip (SoC) designs and chiplets. The company's growth is fueled by the increasing sophistication and complexity of SoCs, including their disaggregation into systems, which drives demand for advanced System IP. The rapid expansion of AI and Generative AI applications is transforming the semiconductor industry, creating new growth opportunities for the company. Arteris's technology offers cost-effective solutions and reduces the risks associated with building in-house Networks-on-Chip (NoC) teams, contributing to its market share growth. The company collaborates with industry leaders like Synopsys, Cadence, and Alphawave for die-to-die interfaces. The semiconductor industry is highly cyclical, characterized by rapid technological change, product obsolescence, competitive pricing pressures, and fluctuations in supply and demand. U.S. export regulations, particularly those targeting advanced AI or supercomputer chip development in China, are noted as a factor that may limit or adversely impact the company's ability to license or support products in China.

Comparison to Industry Standards

• Arteris competes against larger companies like Arm and Cadence, which possess substantial financial, technical, research and development, and engineering resources, indicating a highly competitive landscape.
• The company's strategy of offering cost-effective solutions and reducing the need for in-house NoC teams aligns with a competitive advantage in the semiconductor IP market.
• Arteris's focus on automotive, enterprise computing, communications, consumer electronics, and industrial markets positions it within key growth sectors of the semiconductor industry, particularly with the increasing adoption of sophisticated automated driving technologies.
• The company's significant investment in research and development and its expansion into adjacent markets, such as SoC Integration Automation software through acquisitions like Magillem and Semifore, reflect common industry strategies to address evolving design challenges and broaden product offerings.
• The reliance on royalty revenue, with a substantial time lag between design wins and mass production, is a characteristic of the semiconductor IP licensing model, making revenue prediction challenging and subject to end-market conditions.

Legal Proceedings

• Claims against the company by Network System Technologies, LLC (NST) in the United States District Court for the Western District of Texas were dismissed without prejudice on September 4, 2024. The court will maintain jurisdiction solely for enforcing discovery. No new claims involving the company or customer indemnity claims in connection with this litigation have been received.

Related Party Transactions

• On November 15, 2024, the company entered into a design services licensing collaboration agreement with Transchip Technology (Nanjing) Co., Ltd., an equity method investee.
• During the three months ended March 31, 2025, a three-year term license was delivered to Transchip under this arrangement.
• During the three months ended June 30, 2025, the company reassessed the agreement with Transchip and concluded that the criteria for the existence of the contract under ASC 606 were not met as of June 30, 2025.
• This reassessment resulted in a reversal of $0.7 million to both accounts receivable and deferred revenue. The impact on revenue was not material in any period.

Stakeholder Impact

• Shareholders face potential dilution risk if additional equity securities are issued for future financing, and continued net losses and an increasing accumulated deficit negatively impact shareholder equity. No dividends are expected in the foreseeable future. The stock price may experience volatility due to various factors, and K. Charles Janac's significant ownership (22.2%) allows him to exert substantial control. Anti-takeover provisions may limit opportunities for premium acquisition.
• Employees may see job growth due to increased headcount in research and development and sales and marketing. Stock-based compensation is a significant part of their compensation. However, there is a risk of losing key and highly skilled personnel due to intense competition for talent or stock price volatility.
• Customers benefit from the company's continued product development and support, as indicated by increased Confirmed Design Starts. However, they may experience delays in product development due to external factors, and U.S. export restrictions on China may limit product availability for certain customers. There is also a risk of product errors or defects affecting customer designs.
• Suppliers and creditors are impacted by the company's vendor financing arrangements. The financial health of counterparties could affect the company's ability to collect payments.
• Regulatory bodies oversee the company's compliance with various U.S. and international regulations, including export controls, data privacy, and anti-corruption laws. Non-compliance could lead to investigations, fines, and reputational harm.

Next Steps

• Continue to invest significantly in research and development efforts to address rapid technological developments and expand product offerings.
• Continue to evaluate growth opportunities through acquisitions of other businesses.
• Monitor and analyze the full effects of the recently enacted "One Big Beautiful Bill Act" (OBBBA) on consolidated financial statements, with impacts to be included in Q3 2025.
• Transchip, the equity method investee, is expected to raise additional capital to continue its operations.
• Continue to comply with U.S. export regulations and take additional review and precautions as required when such regulations are updated or changed by the U.S. federal government.

Key Dates

Recommendation

Arteris, Inc. demonstrates strong top-line growth with significant increases in revenue, Annual Contract Value, and Confirmed Design Starts, indicating healthy customer adoption and market traction for its semiconductor IP solutions, particularly in the AI/ML and automotive sectors. However, this growth is accompanied by persistent net losses and a growing accumulated deficit, reflecting substantial investments in research and development and sales and marketing. The company's cash flow from operations has declined, and its equity method investment in Transchip continues to be a financial drain, requiring additional capital. Furthermore, the business faces considerable geopolitical and trade policy risks, especially concerning its operations and revenue from China. While the long-term potential in advanced SoC and AI markets is compelling, the current financial performance and inherent risks suggest a "Hold" recommendation, advising investors to monitor the path to profitability and the impact of external market dynamics.

Keywords

Semiconductor IP, Networks-on-Chip, NoC, System-on-Chip, SoC, AI/ML, Automotive, Enterprise Computing, Communications, Consumer Electronics, Industrial, SoC Integration Automation, IP licensing, Royalties, Semiconductor Industry, Chiplets, Multi-chip package, Intellectual Property, EDA, Electronic Design Automation